Good for Business, Internet, Latvia, Markets and Companies, Technology
International Internet Magazine. Baltic States news & analytics
Saturday, 02.08.2025, 09:54
Tieto Latvia IT company raises turnover 8.3% in 2019

![]() |
---|
Last year, software maintenance generated EUR 14.078 mln in
revenue, software installation, testing and adjusting brought in EUR 9.088 mln
and outsourced services generated EUR 8.694 mln.
License sales generated EUR 6.294 mln, maintenance of
partners' products provided EUR 1.736 mln, provision of training services
generated EUR 117,657 and other revenue came to EUR 4.195 mln.
According to the company's management, last year, Tieto
Latvia continued to work on projects in financial services, the public
sector, energy and infrastructure, as well as in logistics and manufacture.
Finland's TietoEvry, which is the sole owner of Tieto
Latvia and Evry Latvia, has decided to merge the two companies into
one under the name of TietoEvry. After the merger, EVRY Latvia
will cease to exist as a legal entity, all rights and liabilities taken over by
Tieto Latvia.
Tieto Latvia in 2018 posted EUR 40.902 mln in turnover and
EUR 5.511 mln in profit. Tieto Latvia was registered in 1994, and its
share capital is EUR 442,000. Its sole owner is Finland's TietoEvry.
- 28.01.2022 BONO aims at a billion!
- 26.08.2021 LLC Dizozols Investments finalizes investment attraction deal with Crowdestor with record-high profits
- 13.02.2021 Моя жизнь в газете. Очерки по новейшей истории Латвии. Глава 1
- 25.01.2021 Как банкиры 90-х делили «золотую милю» в Юрмале
- 30.12.2020 Накануне 25-летия Балтийский курс/The Baltic Course уходит с рынка деловых СМИ
- 30.12.2020 On the verge of its 25th anniversary, The Baltic Course leaves business media market
- 30.12.2020 Business Education Plus предлагает анонсы бизнес-обучений в январе-феврале 2021 года
- 30.12.2020 Hotels showing strong interest in providing self-isolation service
- 30.12.2020 EU to buy additional 100 mln doses of coronavirus vaccine
- 30.12.2020 ЕС закупит 100 млн. дополнительных доз вакцины Biontech и Pfizer